Viewing nowMegatelmisartan 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

MFDS item code 202000420 · Approved 2020.01.28 · Insurance code 060500520
Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication effectively controls blood pressure in patients with essential hypertension, helping to reduce the risk of cardiovascular diseases. It is particularly suitable for patients over 55 years of age who are at high risk for cardiovascular disease and cannot be given ACE inhibitors. These patients may include those with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or clinical evidence of end-organ damage in high-risk diabetes. This medication is used to reduce the risk of death from myocardial infarction, stroke, and cardiovascular diseases. Therefore, it contributes to improving cardiovascular health and preventing serious complications.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medicines may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can pose serious risks to the fetus and neonates during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication. Patients with severely impaired liver function or issues with bile excretion should avoid this medication. Those with specific genetic disorders should also refrain from taking this drug. Elderly patients, patients with decreased kidney function, and patients with high serum potassium levels should use this medication with caution. Patients with heart disease or gastrointestinal disorders should also be cautious. During treatment with this medication, blood pressure, kidney function, and electrolyte levels should be monitored regularly. Serious side effects such as angioedema, hyperkalemia, and renal impairment may occur; consult a healthcare provider immediately if symptoms appear. Interactions may occur when combined with other antihypertensive drugs or specific medications, so it is essential to inform healthcare providers. This medication may cause symptoms such as hypotension, dizziness, and acute renal failure in the case of overdose; caution is advised. Safety and efficacy have not been established for children, so it is not recommended. Caution is required when driving or operating machinery due to the possibility of dizziness or fainting. Keep out of the reach of children and do not transfer the medication to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage helps to maintain the drug's effectiveness and safety.
White oblong tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
LNC Bio Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.